A method for measuring glycation of red blood cells using physical and electrical properties, a method for measuring glycated hemoglobin levels using the same, and an apparatus for performing this measurement.
A microfluidic device measures glycated hemoglobin levels by analyzing red blood cell passage time through electrode sections, addressing the limitations of existing devices for home-use glycated hemoglobin monitoring with improved accuracy and user-friendly operation.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- ORANGE BIOMED CO LTD
- Filing Date
- 2026-02-04
- Publication Date
- 2026-05-26
AI Technical Summary
Existing glycated hemoglobin measuring devices are limited to hospital and laboratory settings, have short equipment lifespan, require complex storage methods, and suffer from low measurement accuracy due to user proficiency, necessitating a method for reliable home-use glycated hemoglobin measurement.
A household device using microfluidic flow path technology measures glycated hemoglobin by analyzing changes in the physical properties of red blood cells through impedance changes in a microchannel with electrode sections, calculating glycated hemoglobin levels based on passage time and user-specific reference values.
The device provides stable and accurate glycated hemoglobin measurements by minimizing external and human factor influence, enabling reliable home-use monitoring and personalized clinical decision-making.
Smart Images

Figure 2026086563000001_ABST